Chase Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
1,660
+1,353
+441% +$1.38M 0.42% 48
2026
Q1
$281K Buy
+307
New +$311K 0.07% 128
2024
Q3
Sell
-1,264
Closed -$1.14M 133
2024
Q2
$1.14M Sell
1,264
-2
-0.2% -$1.6K 0.41% 59
2024
Q1
$984K Buy
+1,266
New +$901K 0.37% 72

Other funds holding LLY

Chase Investment Counsel's LLY Position: Q2 2026 in Review

Chase Investment Counsel increased its Eli Lilly (LLY) stake by 441% in Q2 2026, buying an estimated $1.38M and bringing the position to 1,660 shares worth $1.99M. The position accounts for 0.42% of the portfolio, ranked #48.

Chase Investment Counsel first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chase Investment Counsel held 1,660 shares of Eli Lilly worth $1.99M as of Q2 2026.
  • Chase Investment Counsel bought 1,353 Eli Lilly shares in Q2 2026, an estimated $1.38M.
  • Eli Lilly made up 0.42% of Chase Investment Counsel's portfolio in Q2 2026, its #48 holding.
  • Chase Investment Counsel first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.